Wells Fargo analyst Joseph O’Dea lowered the firm’s price target on Emerson (EMR) to $140 from $145 and keeps an Overweight rating on the shares. The firm thinks initial 2025 guidance in the space will drive negative revisions in consensus estimates. Recent dollar strength is a large driver of the headwind, Wells adds, noting that it believes currency pressure is largely appreciated, so initial guidance ranges below consensus shouldn’t come as a big surprise.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EMR:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue